FDA Product Code DQK: Computer, Diagnostic, Programmable
FDA product code DQK covers programmable diagnostic computers used in cardiovascular medicine.
These systems acquire, process, and analyze cardiovascular signals — including ECG, hemodynamic data, and intracardiac electrograms — to support diagnosis and treatment decisions. They are used in cardiac catheterization labs, electrophysiology suites, and intensive care units.
DQK devices are Class II medical devices, regulated under 21 CFR 870.1425 and reviewed by the FDA Cardiovascular panel.
Leading manufacturers include Biosense Webster, Inc., St Jude Medical and Abbott Medical.
FDA 510(k) Cleared Computer, Diagnostic, Programmable Devices (Product Code DQK)
About Product Code DQK - Regulatory Context
510(k) Submission Activity
434 total 510(k) submissions under product code DQK since 1976, with 434 receiving FDA clearance (average review time: 141 days).
Submission volume has increased in recent years - 46 submissions in the last 24 months compared to 36 in the prior period - suggesting growing market activity in this device classification.
FDA 510(k) Review Time - DQK Product Code
FDA review times for DQK submissions have been consistent, averaging 130 days recently vs 143 days historically.
DQK devices are reviewed by the Cardiovascular panel. Browse all Cardiovascular devices →